Buscar
Mostrando ítems 21-30 de 741
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group
(Associação Brasileira de Divulgação Científica, 2004)
Post-ganglionic Horner's syndrome: An unusual presentation of non-Hodgkin lymphoma
(2012-01-01)
In this paper, we present the rare case of a patient with cervical lymphadenopathy diagnosed as a T-cell-rich B-cell non-Hodgkin lymphoma that manifested Horner's syndrome due to a post-ganglionic sympathetic neuron lesion ...
Proliferating cell nuclear antigen (PCNA) in non-Hodgkin's lymphomas: Correlation with working formulation and Kiel classification in formalin-fixed paraffin-embedded material
(1996-03-13)
PCNA is a 36-KD proliferating cell nuclear antigen associated with the cell cycle. The immunocytochemical detection of PCNA represents a useful tool for the study of tumor proliferation activity. This study documents the ...
Proliferating cell nuclear antigen (PCNA) in non-Hodgkin's lymphomas: Correlation with working formulation and Kiel classification in formalin-fixed paraffin-embedded material
(1996-03-13)
PCNA is a 36-KD proliferating cell nuclear antigen associated with the cell cycle. The immunocytochemical detection of PCNA represents a useful tool for the study of tumor proliferation activity. This study documents the ...
Post-ganglionic Horner's syndrome: An unusual presentation of non-Hodgkin lymphoma
(2012-01-01)
In this paper, we present the rare case of a patient with cervical lymphadenopathy diagnosed as a T-cell-rich B-cell non-Hodgkin lymphoma that manifested Horner's syndrome due to a post-ganglionic sympathetic neuron lesion ...
Reactivación de la enfermedad de Chagas en un paciente con linfoma no HodgkinChagas disease reactivation in a patient non-Hodgkin's lymphoma
(Elsevier, 2014-10)
Chagas disease is a chronic infection caused by the protozoan Trypanosoma cruzi (T. cruzi). It has a worldwide distribution affecting at least 8---10 million people. In nonendemic countries, Chagas disease is an emerging ...
Utilidad de la deoxiglucosa marcada con flúor-18 (FDG) en el manejo de los linfomas
(Sociedad Médica de Santiago, 2006)
Bone marrow and peripheral blood natural killer cell activity in lymphomas. Its response to IL-2
(Clin. exp. Immunol., 2015)